Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

387
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
387
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

326
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
326
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

217
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
217
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

247
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
247
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

422
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term Surgical Outcomes After Transanal Restorative Proctocolectomy With IPAA: A Comparison of Close Rectal Dissection and Modified Total Mesorectal Excision.

Diseases of the colon and rectum·2026
Same author

Female sexual health after obstetric anal sphincter injury: a scoping review.

Sexual medicine reviews·2026
Same author

Blood culture diagnostics - a comparative and experimental study on the impact of delayed incubation.

BMC microbiology·2026
Same author

The surgical management of perforated diverticulitis Hinchey III: a systematic review and meta-analysis.

International journal of colorectal disease·2025
Same author

Long-term comparative outcomes after ileocecal resection for inflammatory versus complicated Crohn's disease. A multicenter, retrospective study (Crohn's-Urg).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

[Pouchitis].

Ugeskrift for laeger·2025

Related Experiment Video

Updated: Sep 13, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.6K

[Ileocaecal Crohn's disease].

Jonas Horne Grønfeldt1, Louise Thomsen1, Asger Eller1,2

  • 1Kirurgi, Regionshospitalet Viborg.

Ugeskrift for Laeger
|August 1, 2025
PubMed
Summary

For early ileocaecal Crohn's disease, combining surgery with biologics may offer better outcomes than standard treatments. Early surgery can lead to long-term remission and fewer medication needs, particularly for short-segment disease.

Area of Science:

  • Gastroenterology
  • Surgical Gastroenterology
  • Immunology

Background:

  • Treatment strategies for localized ileocaecal Crohn's disease remain a subject of debate.
  • Current options include surgery and medical therapy, with varying long-term outcomes.
  • Anti-TNF-alpha agents are a common first-line medical treatment, yet many patients still require surgery within a decade.

Purpose of the Study:

  • To review and synthesize evidence on early treatment strategies for localized ileocaecal Crohn's disease.
  • To evaluate the comparative effectiveness of early surgery versus medical therapy.
  • To explore the potential benefits of combining surgical and biological treatments.

Main Methods:

  • Literature review of studies comparing early surgery, medical therapy, and combination approaches.

More Related Videos

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.3K
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

479

Related Experiment Videos

Last Updated: Sep 13, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.6K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.3K
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

479
  • Analysis of evidence regarding remission rates, need for further therapy, and long-term outcomes.
  • Consideration of disease extent, patient health status, and treatment risks.

    • Main Results:

    • Early surgery can achieve long-term drug-free remission and reduce subsequent therapy requirements, especially in short-segment disease.
    • While first-line medical treatments like anti-TNF-alpha agents are often effective initially, 40-50% of patients eventually need surgery.
    • Emerging evidence suggests that a combined approach of early surgery and biologics may enhance patient outcomes.

    Conclusions:

    • The optimal early treatment for localized ileocaecal Crohn's disease is not definitively established and requires individualized consideration.
    • Combining early surgical intervention with biologic therapy shows promise for improving outcomes.
    • Treatment decisions must be tailored based on disease characteristics, patient well-being, and potential risks.